105.690 articles found

Clinical, PET/CT, and Longitudinal Progression Characteristics of GBA-Associated Parkinson’s Disease in a Northeast China Cohort

Du X, Wang X, Shen P, Liang Y, Lin X, Chen J, Pan L, Zhang Y.

· 2026-05-26

DOI: 10.21203/rs.3.rs-9697285/v1

iPSC-derived extracellular vesicles rescue deficits in human and mouse models of Parkinson’s disease

Rike WA, Tripathi U, Hussien Y, Choudhary A, Rajkovic A, Sharma O, Rosh I, Manole A, Gage FH, Houlden H, Brodski C, Stern S.

· 2026-05-26

DOI: 10.64898/2026.05.19.726142

Aberrant cortical–subcortical somatosensory network organization is associated with impaired tactile-motion perception in akinetic-rigid Parkinson’s disease

Qu B, Jiang Y, Yue Y, Shen T, Gao C, Huang D, Shen Y, De Zeeuw C, Zhang B, Lai H.

· 2026-05-26

DOI: 10.64898/2026.05.21.726534

Attentive Prototype Learning with Wearable Sensor Mutual Information for Fall Risk Stratification of Parkinson’s Patients

Zhang M, Ren X, Xu J, Guo Z, Qu Q, Chen D, Cao H.

Bioengineering (Basel, Switzerland) · 2026-05-26

Identification of Gene Signatures and Molecular Mechanisms for Diagnosing Parkinson's Disease and Nonalcoholic Fatty Liver Disease Using Machine Learning.

Chen X, Wu Y, Zhang Y, Hou Y.

Parkinsons Dis · 2026-05-26

DOI: 10.1155/padi/8731032PMID: 42205493

Multispectral 7 Tesla MRI as a potential predictor of dopamine transporter deficiency in Parkinson's disease.

Özer M, Egger B, Mennecke A, Nagel A, Zaiss M, Laun FB, Dörfler A, Winkler J, German A.

Imaging Neurosci (Camb) · 2026-05-26

DOI: 10.1162/imag.a.1241PMID: 42212222

Nationwide analysis of real-world access to and use of device-aided therapies in Parkinson's disease: insights from the French National Healthcare Data System (2015-2021).

Auffret M, Nowak E, Vérin M, Kerbrat S.

BMJ Neurol Open · 2026-05-26

DOI: 10.1136/bmjno-2026-001577PMID: 42220614

Exploration of the longitudinal clinical course and potential prognostic factors in Parkinson's disease: 2.5-year observational study in Japan.

Ishikawa KI, Tominaga Y, Kigoshi-Tansho Y, Ohta K, Suzuki A, Li Y, Akamatsu W, Saiki S, Hattori N.

Front Neurol · 2026-05-26

DOI: 10.3389/fneur.2026.1845594PMID: 42273026

Toward common treatment strategies: convergent proteinopathies and mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.

Offerdahl JEV, Mor DE.

Front Neurosci · 2026-05-26

DOI: 10.3389/fnins.2026.1846384PMID: 42273369

Structural covariance network alterations across the spectrum of cognitive status in Parkinson's disease.

Shibata H, Uchida Y, Sakurai K, Tanaka K, Kano Y, Matsukawa N.

Clin Park Relat Disord · 2026-05-26

DOI: 10.1016/j.prdoa.2026.100456PMID: 42282907

Parkinson's disease drug therapies in the clinical trial pipeline: 2015-2024.

Buff S, Pilcicka A, Pitzer K, Fiske B, Stott SR, McFarthing K.

J Parkinsons Dis · 2026-05-26

DOI: 10.1177/1877718x261454154PMID: 42187233

Cryopreservable dopaminergic progenitors derived from human iPSCs with accelerated loss of pluripotency and early functional restoration in Parkinsonian rats.

Chang CY, Chiang CY, Ting HC, Tsai YJ, Chan PC, Chen MF, Guo YT, Liu YH, Chen YS, Chuang CH, Lin PC, Chuang LH, Huang MH, Tung YC, Chen PY, Harn HJ, Su HL, Lin SZ.

NPJ Parkinsons Dis · 2026-05-26

DOI: 10.1038/s41531-026-01399-4PMID: 42191734